A Phase Ib study on C-1205 for the Prevention of Catheter-Associated Urinary Tract Infections (CAUTI)
Latest Information Update: 09 Dec 2010
At a glance
- Drugs C 1205 (Primary)
- Indications Bacterial infections; Urinary tract infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Atterx Biotherapeutics
- 23 Apr 2009 New trial record